Biography
Allene M. Diaz
President, AMD Portfolio Management Consulting
Allene Diaz leads AMD Consulting, a new product strategy and portfolio management consulting practice where she currently serves as Senior Advisor to Xilio Therapeutics.
Ms. Diaz was Senior Vice President, R&D Portfolio Management at GlaxoSmithKline until June 2020. From 2015 to 2019, she served as Senior Vice President of Global Commercial Development and Program Strategy and as a member of the Executive Leadership Team at TESARO Inc.
Prior to joining TESARO, Ms. Diaz held a variety of roles in the EMD Serono and Merck Serono divisions of Merck KGaA, including Senior Vice President, Managed Markets, Senior Vice President, Head of U.S. Oncology Commercial, Vice President, Oncology Marketing and Head of Global Strategic Planning.
Earlier in her career, Ms. Diaz held management, operating, sales, and medical affairs roles at various biopharmaceutical companies, including Pfizer, Parke-Davis, Biogen, and Amylin Pharmaceuticals, among others. She has contributed to the global development, launch and/or commercialization of multiple transformative products across several therapeutic areas.
She serves on the boards of directors of Mersana Therapeutics, Allena Pharmaceuticals and BCLS Acquisition Corporation. Ms. Diaz served on the board of directors of Erytech Pharma SA from 2016 to 2019.
Ms. Diaz was Senior Vice President, R&D Portfolio Management at GlaxoSmithKline until June 2020. From 2015 to 2019, she served as Senior Vice President of Global Commercial Development and Program Strategy and as a member of the Executive Leadership Team at TESARO Inc.
Prior to joining TESARO, Ms. Diaz held a variety of roles in the EMD Serono and Merck Serono divisions of Merck KGaA, including Senior Vice President, Managed Markets, Senior Vice President, Head of U.S. Oncology Commercial, Vice President, Oncology Marketing and Head of Global Strategic Planning.
Earlier in her career, Ms. Diaz held management, operating, sales, and medical affairs roles at various biopharmaceutical companies, including Pfizer, Parke-Davis, Biogen, and Amylin Pharmaceuticals, among others. She has contributed to the global development, launch and/or commercialization of multiple transformative products across several therapeutic areas.
She serves on the boards of directors of Mersana Therapeutics, Allena Pharmaceuticals and BCLS Acquisition Corporation. Ms. Diaz served on the board of directors of Erytech Pharma SA from 2016 to 2019.